Advik Laboratories Ltd

Advik Laboratories Ltd

Advik Laboratories Ltd has scheduled a Board Meeting on 13/11/2026 to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.

Advik Laboratories Ltd

Advik Laboratories Ltd has submitted a statement of investor complaints for the quarter ended 30th September, 2026, with no complaints pending or received during the quarter.

Advik Laboratories Ltd

Advik Laboratories Ltd (now known as MPS PHARMAA LIMITED) submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended 30th September, 2026. The certificate confirms that securities received for dematerialization were confirmed within 15 days and that the register of members was updated accordingly.

Advik Laboratories Ltd

Advik Laboratories Ltd, now known as MPS Pharmaa Ltd, has announced the outcome of its 32nd Annual General Meeting (AGM) held on September 29, 2026. The shareholders have approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director, the appointment of Ms. Anchal Goyal as an Independent Director, and the re-appointment of M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors.

Advik Laboratories Ltd

Advik Laboratories Ltd (formerly MPS Pharmaa Ltd) has announced the outcome of its 32nd Annual General Meeting (AGM), where all resolutions were passed with the requisite majority. The company has re-appointed Mr. Ram Niwas Sharma as a Non-Executive Director, appointed Ms. Anchal Goyal as an Independent Director, and re-appointed M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors.

Advik Laboratories Ltd

Advik Laboratories Ltd (formerly MPS Pharmaa Ltd) has announced the outcome of its 32nd Annual General Meeting (AGM), where all resolutions were passed with the requisite majority. The company has re-appointed Mr. Ram Niwas Sharma as a Non-Executive Director, appointed Ms. Anchal Goyal as an Independent Director, and re-appointed M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors.

Advik Laboratories Ltd

Advik Laboratories Ltd, now known as MPS Pharmaa Ltd, has announced the outcome of its 32nd Annual General Meeting (AGM) held on September 29, 2026. The shareholders have approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director, appointment of Ms. Anchal Goyal as an Independent Director, and re-appointment of M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors. The company has also approved related party transactions and transactions under Section 185 of the Companies Act, 2013.

Advik Laboratories Ltd

Advik Laboratories Ltd (now MPS Pharmaa Ltd) has announced the outcome of its 32nd Annual General Meeting (AGM), where all resolutions were passed with the requisite majority. The AGM saw the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director, appointment of Ms. Anchal Goyal as an Independent Director, and re-appointment of M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors.

Advik Laboratories Ltd

Advik Laboratories Ltd (now MPS Pharmaa Ltd) has announced the outcome of its 32nd Annual General Meeting (AGM), where all resolutions were passed with the requisite majority. The AGM approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director, appointment of Ms. Anchal Goyal as an Independent Director, and re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors. The company also approved Related Party Transactions and transactions under Section 185 of the Companies Act, 2013.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the appointment of a Non-Executive Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of its statutory auditor.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of its statutory auditor.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the appointment of a Non-Executive Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the appointment of a Non-Executive Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of its statutory auditor.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES L

MPS Pharmaa Limited has informed BSE about the re-appointment of its statutory auditor.